Theranica

Neuromodulation-based Patch for Migraine Relief

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
Theranica
02/07/2022
NeuroModulation
Medical devices | Medical equipment
General wellbeing / wellness (users without clinical diagnosis)
Neuromodulation Interventions | Non-Invasive (TMS | tDCS | tACS)
01/01/2015
"11-50"

Theranica is the developer of Nerivio, a fully integrated, self-contained family of therapeutic patches. The patches and other types of wearables in the company’s pipeline are controlled by smartphone applications to easily adapt therapy treatments to everyday life.



Theranica’s Nerivio Migra is a migraine-relief patch that provides migraine treatment through neuromodulation. Instead of placing electrodes on their head, patients can attach Theranica’s clinically tested, wearable patch on their arm and launch a personalized pain-relief program.



Theranica combines electrical neurostimulation and neuromuscular-stimulation technologies with modern wireless communication and smartphone applications. The company uses these advanced technologies to design and deliver effective products for treating a variety of severe and common medical problems.



In May 2019, Theranica won FDA De Novo clearance for its Nerivio Migra device. In June 2019, the company announced the establishment of a wholly owned subsidiary company, Theranica USA, headquartered in Montclair, New Jersey.



Nerivio appeared on TIME’s List of 100 Best Inventions of 2019. Theranica was also listed as one of 36 game-changing companies in 2020 by New York-based research firm CB Insights.